The Kimberly-Clark Corporation recently announced that it would continue to increase production of facemasks and personal protective equipment in response to ongoing near epidemic levels of influenza in the United States.
Acute care facilities in particular have been responsible for the increase in demand across the nation. Kimberly-Clark said that it is closely monitoring influenza data from the U.S. Centers for Disease Control and Prevention and is adjusting its manufacturing schedules and inventory management accordingly, InfectionControlToday.com reports.
The CDC concluded that the influenza season started earlier this year than usual and has also been substantially more severe.
“The health and safety of our valued customers and their patients is our most important priority,” John Amat, the vice president of sales and marketing for Kimberly-Clark Health Care, said, InfectionControlToday.com reports. “Kimberly-Clark representatives are proactively reaching out to all of our current customers to assure them that with our North America-based product supply, we can continue to provide the highest quality facial protection products throughout the flu season.”
Kimberly-Clark issued its own series of simple precautions to help prevent the spread of the flu, including the CDC’s recommendation that everyone receive the seasonal influenza vaccine. The company also recommends proper hygiene, including the use of alcohol-based hand sanitizer.